Tumor necrosis factor receptors 6α and 6β
    1.
    发明授权
    Tumor necrosis factor receptors 6α and 6β 失效
    肿瘤坏死因子受体6α和6&bgr;

    公开(公告)号:US08003386B1

    公开(公告)日:2011-08-23

    申请号:US09006352

    申请日:1998-01-13

    CPC分类号: C07K14/70578

    摘要: The present invention relates to novel Tumor Necorsis Factor Receptor proteins. In particular, isolated nucleic acid molecules are provided encoding the human TNFR-6α & -6β proteins. TNFR-6α & -6β polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of TNFR-6α & -6β activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.

    摘要翻译: 本发明涉及新型肿瘤坏死因子受体蛋白。 特别地,提供编码人TNFR-6α&-6&bgr的分离的核酸分子; 蛋白质。 TNFR-6α&-6&bgr; 还提供多肽,载体,宿主细胞以及用于制备它们的重组方法。 本发明还涉及用于鉴定TNFR-6α和-6β的激动剂和拮抗剂的筛选方法。 活动。 还提供了用于检测免疫系统相关疾病的诊断方法和用于治疗免疫系统相关疾病的治疗方法。

    Tumor Necrosis Factor Receptors 6 Alpha & 6 Beta
    2.
    发明申请
    Tumor Necrosis Factor Receptors 6 Alpha & 6 Beta 审中-公开
    肿瘤坏死因子受体6 Alpha&6 Beta

    公开(公告)号:US20060234285A1

    公开(公告)日:2006-10-19

    申请号:US11419656

    申请日:2006-05-22

    摘要: The present invention relates to novel Tumor Necrosis Factor Receptor proteins. In particular, isolated nucleic acid molecules are provided encoding the human TNFR-6α & -6β proteins. TNFR-6α & -6β polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of TNFR-6α & -6β activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.

    摘要翻译: 本发明涉及新型肿瘤坏死因子受体蛋白。 特别地,提供编码人TNFR-6α和-6β蛋白的分离的核酸分子。 还提供了TNFR-6α和-6β多肽,载体,宿主细胞和用于制备它们的重组方法。 本发明还涉及鉴定TNFR-6α和-6β活性的激动剂和拮抗剂的筛选方法。 还提供了用于检测免疫系统相关疾病的诊断方法和用于治疗免疫系统相关疾病的治疗方法。